1
|
Harper DJ, Kim Y, Gómez-Ramírez A, Vakoc BJ. Needle guidance with Doppler-tracked polarization-sensitive optical coherence tomography. JOURNAL OF BIOMEDICAL OPTICS 2023; 28:102910. [PMID: 37799938 PMCID: PMC10548115 DOI: 10.1117/1.jbo.28.10.102910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 08/25/2023] [Accepted: 09/22/2023] [Indexed: 10/07/2023]
Abstract
Significance Optical coherence tomography (OCT) can be integrated into needle probes to provide real-time navigational guidance. However, unscanned implementations, which are the simplest to build, often struggle to discriminate the relevant tissues. Aim We explore the use of polarization-sensitive (PS) methods as a means to enhance signal interpretability within unscanned coherence tomography probes. Approach Broadband light from a laser centered at 1310 nm was sent through a fiber that was embedded into a needle. The polarization signal from OCT fringes was combined with Doppler-based tracking to create visualizations of the birefringence properties of the tissue. Experiments were performed in (i) well-understood structured tissues (salmon and shrimp) and (ii) ex vivo porcine spine. The porcine experiments were selected to illustrate an epidural guidance use case. Results In the porcine spine, unscanned and Doppler-tracked PS OCT imaging data successfully identified the skin, subcutaneous tissue, ligament, and epidural spaces during needle insertion. Conclusions PS imaging within a needle probe improves signal interpretability relative to structural OCT methods and may advance the clinical utility of unscanned OCT needle probes in a variety of applications.
Collapse
Affiliation(s)
- Danielle J. Harper
- Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, Massachusetts, United States
- Harvard Medical School, Boston, Massachusetts, United States
| | - Yongjoo Kim
- Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, Massachusetts, United States
- Harvard Medical School, Boston, Massachusetts, United States
| | - Alejandra Gómez-Ramírez
- Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, Massachusetts, United States
- Universidad Nacional de Colombia sede Medellín, School of Physics, Medellín, Colombia
| | - Benjamin J. Vakoc
- Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, Massachusetts, United States
- Harvard Medical School, Boston, Massachusetts, United States
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, United States
| |
Collapse
|
2
|
Scolaro L, Lorenser D, Quirk BC, Kirk RW, Ho LA, Thomas E, Li J, Saunders CM, Sampson DD, Fuller RO, McLaughlin RA. Multimodal imaging needle combining optical coherence tomography and fluorescence for imaging of live breast cancer cells labeled with a fluorescent analog of tamoxifen. JOURNAL OF BIOMEDICAL OPTICS 2022; 27:076004. [PMID: 35831923 PMCID: PMC9278982 DOI: 10.1117/1.jbo.27.7.076004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Accepted: 06/28/2022] [Indexed: 06/15/2023]
Abstract
SIGNIFICANCE Imaging needles consist of highly miniaturized focusing optics encased within a hypodermic needle. The needles may be inserted tens of millimeters into tissue and have the potential to visualize diseased cells well beyond the penetration depth of optical techniques applied externally. Multimodal imaging needles acquire multiple types of optical signals to differentiate cell types. However, their use has not previously been demonstrated with live cells. AIM We demonstrate the ability of a multimodal imaging needle to differentiate cell types through simultaneous optical coherence tomography (OCT) and fluorescence imaging. APPROACH We characterize the performance of a multimodal imaging needle. This is paired with a fluorescent analog of the therapeutic drug, tamoxifen, which enables cell-specific fluorescent labeling of estrogen receptor-positive (ER+) breast cancer cells. We perform simultaneous OCT and fluorescence in situ imaging on MCF-7 ER+ breast cancer cells and MDA-MB-231 ER- cells. Images are compared against unlabeled control samples and correlated with standard confocal microscopy images. RESULTS We establish the feasibility of imaging live cells with these miniaturized imaging probes by showing clear differentiation between cancerous cells. CONCLUSIONS Imaging needles have the potential to aid in the detection of specific cancer cells within solid tissue.
Collapse
Affiliation(s)
- Loretta Scolaro
- The University of Adelaide, Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
- The University of Adelaide, Institute for Photonics and Advanced Sensing, Adelaide, South Australia, Australia
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
| | - Dirk Lorenser
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
| | - Bryden C. Quirk
- The University of Adelaide, Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
- The University of Adelaide, Institute for Photonics and Advanced Sensing, Adelaide, South Australia, Australia
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
| | - Rodney W. Kirk
- The University of Adelaide, Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
- The University of Adelaide, Institute for Photonics and Advanced Sensing, Adelaide, South Australia, Australia
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
| | - Louisa A. Ho
- The University of Western Australia, School of Molecular Sciences, Crawley, Western Australia, Australia
| | - Elizabeth Thomas
- The University of Western Australia, Medical School, Division of Surgery, Nedlands, Western Australia, Australia
| | - Jiawen Li
- The University of Adelaide, Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
- The University of Adelaide, Institute for Photonics and Advanced Sensing, Adelaide, South Australia, Australia
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
- The University of Adelaide, School of Electrical and Electronic Engineering, Adelaide, South Australia, Australia
| | - Christobel M. Saunders
- The University of Western Australia, Medical School, Division of Surgery, Nedlands, Western Australia, Australia
- Fiona Stanley Hospital, Breast Centre, Murdoch, Western Australia, Australia
- Royal Perth Hospital, Breast Clinic, Perth, Western Australia, Australia
| | - David D. Sampson
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
- University of Surrey, School of Biosciences and Medicine, Surrey Biophotonics, Guildford, United Kingdom
- University of Surrey, Advanced Technology Institute, School of Physics, Surrey Biophotonics, Guildford, United Kingdom
| | - Rebecca O. Fuller
- The University of Western Australia, School of Molecular Sciences, Crawley, Western Australia, Australia
- University of Tasmania, School of Natural Sciences – Chemistry, Hobart, Tasmania, Australia
| | - Robert A. McLaughlin
- The University of Adelaide, Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia
- The University of Adelaide, Institute for Photonics and Advanced Sensing, Adelaide, South Australia, Australia
- The University of Western Australia, School of Engineering, Optical+Biomedical Engineering Laboratory, Crawley, Western Australia, Australia
| |
Collapse
|
3
|
van Riel LAMJG, Swaan A, Mannaerts CK, van Kollenburg RAA, Savci Heijink CD, de Reijke TM, de Bruin DM, Freund JE. Image-guided in-Vivo Needle-Based Confocal Laser Endomicroscopy in the Prostate: Safety and Feasibility Study in 2 Patients. Technol Cancer Res Treat 2022; 21:15330338221093149. [PMID: 35790459 PMCID: PMC9272180 DOI: 10.1177/15330338221093149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Purpose: To assess the safety and technical feasibility of in-vivo needle-based forward-looking confocal laser endomicroscopy in prostate tissue. Methods: For this feasibility study, 2 patients with a suspicion of prostate cancer underwent transperineal needle-based confocal laser endomicroscopy during ultrasound-guided transperineal template mapping biopsies. After intravenous administration of fluorescein, needle-based confocal laser endomicroscopy imaging was performed with a forward-looking probe (outer diameter 0.9 mm) in 2 trajectories during a manual push-forward and pullback motion. A biopsy was taken in a coregistered parallel adjacent trajectory to the confocal laser endomicroscopy trajectory for histopathologic comparison. Peri- and postprocedural adverse events, confocal laser endomicroscopy device malfunction and procedural failures were recorded. Needle-based confocal laser endomicroscopy image quality assessment, image interpretation, and histology were performed by an experienced confocal laser endomicroscopy rater and uro-pathologist, blinded to any additional information. Results: In both patients, no peri- and post-procedural adverse events were reported following needle-based confocal laser endomicroscopy. No confocal laser endomicroscopy device malfunction nor procedural failures were reported. Within 1.5 min after intravenous administration of fluorescein, needle-based confocal laser endomicroscopy image quality was sufficient for interpretation for at least 14 min, yielding more than 5000 confocal laser endomicroscopy frames per patient. The pullback confocal laser endomicroscopy recordings and most of the push-forward recordings almost only visualized erythrocytes, being classified as non-representative. During the push-forward recordings, prostate tissue was occasionally visualized in single frames, insufficient for histopathologic comparison. Prostate carcinoma was identified by biopsy in one patient (Gleason score 4 + 3 = 7, >50%), while the biopsy from the other patient showed no malignancy. Conclusion: Needle-based confocal laser endomicroscopy imaging of in-vivo prostate tissue with a forward-looking confocal laser endomicroscopy probe is safe without device malfunctions or procedural failures. Needle-based confocal laser endomicroscopy is technically feasible, but the acquired confocal laser endomicroscopy datasets are non-representative. The confocal laser endomicroscopy images’ non-representative nature is possibly caused by bleeding artifacts, movement artifacts and a lack of contact time with the tissue of interest. A different confocal laser endomicroscopy probe or procedure might yield representative images of prostatic tissue.
Collapse
Affiliation(s)
- Luigi A M J G van Riel
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.,Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Abel Swaan
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.,Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Christophe K Mannaerts
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Rob A A van Kollenburg
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - C Dilara Savci Heijink
- Department of Pathology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Theo M de Reijke
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Daniel M de Bruin
- Department of Urology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.,Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| | - Jan Erik Freund
- Department of Pathology, 26066Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
| |
Collapse
|
4
|
Abdurashitov AS, Prikhozhdenko ES, Mayorova OA, Plastun VO, Gusliakova OI, Shushunova NA, Kulikov OA, Tuchin VV, Sukhorukov GB, Sindeeva OA. Optical coherence microangiography of the mouse kidney for diagnosis of circulatory disorders. BIOMEDICAL OPTICS EXPRESS 2021; 12:4467-4477. [PMID: 34457426 PMCID: PMC8367229 DOI: 10.1364/boe.430393] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 06/17/2021] [Accepted: 06/20/2021] [Indexed: 05/02/2023]
Abstract
Optical coherence tomography (OCT) has become widespread in clinical applications in which precise three-dimensional functional imaging of living organs is required. Nevertheless, the kidney is inaccessible for the high resolution OCT imaging due to a high light attenuation coefficient of skin and soft tissues that significantly limits the penetration depth of the probing laser beam. Here, we introduce a surgical protocol and fixation scheme that enables functional visualization of kidney's peritubular capillaries via OCT microangiography. The model of reversible/irreversible glomerulus embolization using drug microcarriers confirms the ability of OCT to detect circulatory disorders. This approach can be used for choosing optimal carriers, their dosages and diagnosis of other blood flow pathologies.
Collapse
Affiliation(s)
- Arkady S Abdurashitov
- Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, 3 Nobel str., Moscow 143005, Russia
| | | | - Oksana A Mayorova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
| | - Valentina O Plastun
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
| | - Olga I Gusliakova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
| | - Natalia A Shushunova
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
| | - Oleg A Kulikov
- Ogarev Mordovia State University, 68 Bolshevistskaya str., Saransk 430005, Russia
| | - Valery V Tuchin
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
- Interdisciplinary Laboratory of Biophotonics, National Research Tomsk State University, 36 Lenina Avenue, Tomsk 634050, Russia
- Laboratory of Laser Diagnostics of Technical and Living Systems, Institute of Precision Mechanics and Control of the Russian Academy of Science, 24 Rabochaya Str., Saratov 410028, Russia
| | - Gleb B Sukhorukov
- Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, 3 Nobel str., Moscow 143005, Russia
- School of Engineering and Materials Science, Queen Mary University of London, Mile End, Eng, 215, London E1 4NS, United Kingdom
| | - Olga A Sindeeva
- Skolkovo Institute of Science and Technology, Skolkovo Innovation Center, 3 Nobel str., Moscow 143005, Russia
- Science Medical Center, Saratov State University, 83 Astrakhanskaya str., Saratov 410012, Russia
| |
Collapse
|
5
|
Swaan A, Muller BG, Wilk LS, Almasian M, Zwartkruis ECH, Rozendaal LR, de Bruin DM, Faber DJ, van Leeuwen TG, van Herk MB. En-face optical coherence tomography for the detection of cancer in prostatectomy specimens: Quantitative analysis in 20 patients. JOURNAL OF BIOPHOTONICS 2020; 13:e201960105. [PMID: 32049426 DOI: 10.1002/jbio.201960105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 01/10/2020] [Accepted: 01/27/2020] [Indexed: 06/10/2023]
Abstract
The increase histopathological evaluation of prostatectomy specimens rises the workload on pathologists. Automated histopathology systems, preferably directly on unstained specimens, would accelerate the pathology workflow. In this study, we investigate the potential of quantitative analysis of optical coherence tomography (OCT) to separate benign from malignant prostate tissue automatically. Twenty fixated prostates were cut, from which 54 slices were scanned by OCT. Quantitative OCT metrics (attenuation coefficient, residue, goodness-of-fit) were compared for different tissue types, annotated on the histology slides. To avoid misclassification, the poor-quality slides, and edges of annotations were excluded. Accurate registration of OCT data with histology was achieved in 31 slices. After removing outliers, 56% of the OCT data was compared with histopathology. The quantitative data could not separate malignant from benign tissue. Logistic regression resulted in malignant detection with a sensitivity of 0.80 and a specificity of 0.34. Quantitative OCT analysis should be improved before clinical use.
Collapse
Affiliation(s)
- Abel Swaan
- Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Berrend G Muller
- Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Leah S Wilk
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Mitra Almasian
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Evita C H Zwartkruis
- Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - L Rence Rozendaal
- Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Daniel M de Bruin
- Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Dirk J Faber
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Ton G van Leeuwen
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Marcel B van Herk
- Department of Biomedical Engineering and Physics, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Institute of Cancer Sciences, University of Manchester, Manchester, UK
- Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
| |
Collapse
|
6
|
Yuan W, Chen D, Sarabia-Estrada R, Guerrero-Cázares H, Li D, Quiñones-Hinojosa A, Li X. Theranostic OCT microneedle for fast ultrahigh-resolution deep-brain imaging and efficient laser ablation in vivo. SCIENCE ADVANCES 2020; 6:eaaz9664. [PMID: 32300661 PMCID: PMC7148106 DOI: 10.1126/sciadv.aaz9664] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 01/15/2020] [Indexed: 05/21/2023]
Abstract
Current minimally invasive optical techniques for in vivo deep-brain imaging provide a limited resolution, field of view, and speed. These limitations prohibit direct assessment of detailed histomorphology of various deep-seated brain diseases at their native state and therefore hinder the potential clinical utilities of those techniques. Here, we report an ultracompact (580 μm in outer diameter) theranostic deep-brain microneedle combining 800-nm optical coherence tomography imaging with laser ablation. Its performance was demonstrated by in vivo ultrahigh-resolution (1.7 μm axial and 5.7 μm transverse), high-speed (20 frames per second) volumetric imaging of mouse brain microstructures and optical attenuation coefficients. Its translational potential was further demonstrated by in vivo cancer visualization (with an imaging depth of 1.23 mm) and efficient tissue ablation (with a 1448-nm continuous-wave laser at a 350-mW power) in a deep mouse brain (with an ablation depth of about 600 μm).
Collapse
Affiliation(s)
- Wu Yuan
- Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
| | - Defu Chen
- Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
| | | | | | - Dawei Li
- Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
| | | | - Xingde Li
- Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
- Corresponding author.
| |
Collapse
|